Determination of atomoxetine or escitalopram in human plasma by HPLC: Applications in neuroscience r...
Determination of atomoxetine or escitalopram in human plasma by HPLC: Applications in neuroscience research studies
About this item
Full title
Author / Creator
Publisher
Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG
Subjects
More information
Scope and Contents
Contents
Atomoxetine and escitalopram are potent and selective drugs approved for noradrenergic or serotonergic modulation of neuronal networks in attention-deficit hyperactivity disorder (ADHD) or depression, respectively. High-performance liquid chromatography (HPLC) methods still play an important role in the therapeutic drug monitoring (TDM) of psychoph...
Alternative Titles
Full title
Determination of atomoxetine or escitalopram in human plasma by HPLC: Applications in neuroscience research studies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7611122
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7611122
Other Identifiers
ISSN
0946-1965
DOI
10.5414/CP203705
